Astera Labs (NASDAQ:ALAB) Shares Down 5% – Time to Sell?

Shares of Astera Labs, Inc. (NASDAQ:ALABGet Free Report) dropped 5% on Friday . The stock traded as low as $289.60 and last traded at $303.62. Approximately 7,202,064 shares traded hands during mid-day trading, an increase of 28% from the average session volume of 5,634,647 shares. The stock had previously closed at $319.74.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of recent analyst reports. UBS Group boosted their price objective on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th. Needham & Company LLC raised their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Stifel Nicolaus lifted their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Barclays boosted their price target on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Finally, Evercore restated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $275.75.

Check Out Our Latest Stock Report on ALAB

Astera Labs Price Performance

The firm’s fifty day moving average price is $347.25 and its two-hundred day moving average price is $220.00. The stock has a market cap of $52.04 billion, a price-to-earnings ratio of 205.15, a price-to-earnings-growth ratio of 3.95 and a beta of 3.66.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the business posted $0.33 EPS. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 139,951 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. This represents a 3.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,700,432 shares of company stock worth $449,062,723. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Accel Wealth Management acquired a new position in Astera Labs during the 2nd quarter valued at about $317,000. Handelsbanken Fonder AB increased its stake in Astera Labs by 11.3% in the 2nd quarter. Handelsbanken Fonder AB now owns 44,500 shares of the company’s stock valued at $21,494,000 after buying an additional 4,500 shares during the last quarter. Redhawk Wealth Advisors Inc. purchased a new stake in Astera Labs in the 2nd quarter valued at about $331,000. Wealthcare Advisory Partners LLC lifted its position in shares of Astera Labs by 0.9% during the 2nd quarter. Wealthcare Advisory Partners LLC now owns 22,845 shares of the company’s stock worth $11,035,000 after buying an additional 201 shares in the last quarter. Finally, Focus Financial Network Inc. bought a new position in shares of Astera Labs during the 2nd quarter worth approximately $711,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.